ID
32198
Descripción
Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on ClinicalStudyDataRequest.com https://clinicaltrials.gov/ct2/show/NCT00466947?term=NCT00466947 Clinicaltrials.gov Identifier: NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains: 1)Report of serious adverse events. It has to be filled in for workbook 1 and visit 1, 2, 3, 4, 5, 6, 7, 8 and 9. 2) Report of unsolicited adverse events. Only for workbook 2. It has to be filled in for visit 1, 2, 3, 4, 5, 6, 7, 8 and 9 3) CAP/ID/AOM case. It also has to be filled in for visit 1, 2, 3, 4, 5, 6, 7, 8 and 9. The AOM case is only for workbook 2.
Link
https://clinicaltrials.gov/ct2/show/NCT00466947?term=NCT00466947
Palabras clave
Versiones (3)
- 17/10/2018 17/10/2018 -
- 23/10/2018 23/10/2018 -
- 26/10/2018 26/10/2018 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
23 de outubro de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Vaccination against pneumonia and otitis media 109563, NCT00466947
Serious adverse events, unsolicited adverse events and CAP/ID/AOM case
Descripción
Unsolicited/serious adverse events
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C4055646
- UMLS CUI-3
- C1519255
Descripción
For workbook 1 and 3 Please fill in the Serious Adverse Event report if SAE was detcted following vaccination.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0332282
- UMLS CUI [1,3]
- C0042196
Descripción
Only for workbook 2
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C4055646
- UMLS CUI [1,2]
- C1519255
- UMLS CUI [1,3]
- C0332282
- UMLS CUI [1,4]
- C0042196
- UMLS CUI [2,1]
- C4055646
- UMLS CUI [2,2]
- C1518404
- UMLS CUI [2,3]
- C0332282
- UMLS CUI [2,4]
- C0042196
Descripción
Please complete an SAE report and the meningitis report if meningitis following vaccination was confirmed. Please also complete the ID section if the meningitis is caused by SP or HI.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0025289
- UMLS CUI [1,2]
- C0332282
- UMLS CUI [1,3]
- C0042196
Descripción
Community-Acquired Pneumonia/invasive disease/acute otitis media case
Alias
- UMLS CUI-1
- C0694549
- UMLS CUI-2
- C4285937
- UMLS CUI-3
- C0029882
- UMLS CUI-4
- C0205178
Descripción
CAP following vaccination
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0694549
- UMLS CUI [1,2]
- C0332282
- UMLS CUI [1,3]
- C0042196
Descripción
ID following vaccination
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C4285937
- UMLS CUI [1,2]
- C0332282
- UMLS CUI [1,3]
- C0042196
Descripción
only for workbook 2.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0029882
- UMLS CUI [1,2]
- C0205178
- UMLS CUI [1,3]
- C0332282
- UMLS CUI [1,4]
- C0042196
Similar models
Serious adverse events, unsolicited adverse events and CAP/ID/AOM case
C4055646 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C0332282 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,2])
C0332282 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,4])
C4055646 (UMLS CUI [2,1])
C1518404 (UMLS CUI [2,2])
C0332282 (UMLS CUI [2,3])
C0042196 (UMLS CUI [2,4])
C0332282 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C4285937 (UMLS CUI-2)
C0029882 (UMLS CUI-3)
C0205178 (UMLS CUI-4)
C0332282 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C0332282 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
C0205178 (UMLS CUI [1,2])
C0332282 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,4])